Advancing Cancer Care for Dogs
Transforming canine cancer treatment through personalized medicine.
Transforming canine
cancer treatment
through
personalized medicine.
Transforming canine
cancer treatment
through personalized medicine.
There’s no “one-size-fits-all” treatment for cancer. That’s why FidoCure® uses genomic testing to determine the best course of action for your dog’s cancer therapy – beyond standard chemo and radiation.
FidoCure® Approach: Genetic testing reveals which targeted therapies may work best for your dog
Precision medicine can offer a hopeful prognosis. FidoCure® was created by dog lovers and scientists on a mission to make effective canine cancer treatment accessible. Our process uses genomic testing in conjunction with tumor type to identify possible cancer-causing mutations. From there, we suggest targeted therapy to precisely attack the cancer cells.
Forrest was diagnosed with splenic cancer and given one month to live.
Through the targeted therapy suggested by FidoCure®, he lived happily for nearly 4 years past his diagnosis.
Forrest, Golden Retriever
Hemophagocytic Histiocytic Sarcoma
Trusted by the Leading Veterinary Oncologists
Thousands of dogs have benefitted from FidoCure® when other options were limited.
Toulouse
“Since starting treatment, Toulouse’s tumors have regressed. FidoCure® brought us hope for Toulouse when we thought we didn’t have any options left.” — Daniel, FL
Lizzie
“Thanks to FidoCure®, Lizzie is 100% active again, eating well, and in remission for 5 months.” — Kimberley and Francois, CT
Gracie
“[Our vet] told us about the One Health Company’s precision medicine solution, FidoCure®… Now, exactly two months later, Gracie’s cancer is in remission.” — The Gonzalez Family, FL
Resources & Education
-
Global Impact from the U.S. to Korea at FAVA 2024
by Christina K. Lopes on October 24, 2024 at 2:00 pm
We are excited to share that Dr. Lucas Rodrigues, FidoCure's Head of Veterinary Research, will be presenting twice at the 23rd Federation […]
-
What are Gastrointestinal Cancers?
by FidoCure on October 22, 2024 at 1:00 pm
Gastrointestinal (GI) tumors in dogs are relatively rare but can be serious when they occur. These tumors affect the stomach, intestines, […]
-
FidoCure To Unveil Breakthrough in Canine Hemangiosarcoma at 2024 Veterinary Cancer Society Annual Conference
by FidoCure on October 11, 2024 at 1:34 pm
PALO ALTO, Calif. (October 15, 2024) — FidoCure, a leader in AI-driven precision oncology for dogs, is excited to share landmark findings […]
-
Pancreatic Cancer in Dogs
by FidoCure on October 10, 2024 at 1:00 pm
Pancreatic cancer, though rare, is a serious condition in dogs, with two of the most common forms being insulinoma and pancreatic […]
-
What to Know About Anal Sac Carcinoma
by FidoCure on September 26, 2024 at 1:00 pm
Anal sac carcinoma is a highly aggressive cancer that develops in the small glandular structures on either side of a dog's anus. These sacs […]
-
FidoCure Leads Canine Cancer Research with the World’s Largest Canine Cancer Database
by FidoCure on September 24, 2024 at 1:00 pm
At FidoCure, we're committed to transforming cancer care for dogs through precision medicine. Our journey began with a mission to address a […]
As Seen On
